Skip to content

To study effect of Rasnadyo Guggulu in ardhavabhedaka(simple migraine)

A randomized controlled clinical trial to study the effect of Rasnadyo Guggulu in the management of ardhavabhedaka with special reference to simple migraine. - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/08/093249
Enrollment
70
Registered
2025-08-19
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G430- Migraine without aura

Interventions

None listed

Sponsors

Dr Prajakta Pundalikrao Akate
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a)Patients having lakshanas of ardhavabhedaka or simple migraine b)Patients between age group og 18 to 60 years c)patients will be included irrespective of sex, religion and caste

Exclusion criteria

Exclusion criteria: a)Patients with complicated migraine/hemiplegic migraine b)patients age below 18 years and above 60 years c)patients having a history of head trauma and other types of headaches d)patients having any inflammatory diseases in nose, PNS, eyes and tears e)patients suffering from other diseases like HIV, DM, HTN, pregnant women

Design outcomes

Primary

MeasureTime frame
Reduction in signs and symptoms of ardhavabhedaka after taking rasnadyo gugguluTimepoint: 15 days

Secondary

MeasureTime frame
where the trial group stands in comparison with control group in reduction with sign and symptoms of ardhavabhedakaTimepoint: 18 months

Countries

India

Contacts

Public ContactSiradram Gurubasappa Vagadurgi

SMBT Ayurved college and Hospital

Vagadurgi.eye@gmail.com9970638273

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026